company

BIOPROCESS AS

5230 PARADIS

Return on Equity
−7 566,67 %
Current Ratio
0,9
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue38 000
Net Income−454 000
Total Assets69 000
Total Equity6 000
Income (NOK)2022
Revenue38 000
Expenditure602 000
Operating Profit−564 000
Financial Income47 000
Financial Costs65 000
Financial Balance−18 000
Earnings Before Tax−582 000
Tax−128 000
Net Income−454 000
Balance (NOK)2022
Total Fixed Assets11 000
Total Current Assets57 000
Total Assets69 000
Total Retained Equity−24 000
Total Equity6 000
Total Long-Term Debt0
Total Current Debt63 000
Total Equity and Debt69 000
Cash flow (NOK)2022
Sales Income38 000
Other Income0
Revenue38 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure602 000
Operating Profit−564 000
Financial Income47 000
Financial Costs65 000
Financial Balance−18 000
Dividends0
Net Income−454 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets7 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets5 000
Total Fixed Assets11 000
Stock0
Total Investments0
Cash, Bank4 000
Total Current Assets57 000
Total Assets69 000
Total Equity6 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors63 000
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt63 000
Total Equity and Debt69 000
Financial indicators2022
Return on Equity−7 566,67 %
Debt-to-Equity Ratio0
Operating Profit Margin−1 484,21 %
Current Ratio0,9
Quick Ratio0,9
Equity Ratio0,09
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English